Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment

This study has been completed.

Study NCT00004584 Information provided by Bristol-Myers Squibb

First Received: February 10, 2000 Last Updated: April 28, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2002
Primary Completion Date:	January 2002 (Final data collection date for primary outcome measure)